Ethyl Acetate → HCID 89816262, 화합물
반응식
[F:1][C:2]([F:37])([F:36])[C:3]1[CH:4]=[C:5]([C:13]2([C:32]([F:35])([F:34])[F:33])[CH2:17][CH2:16][N:15]([C:18]3[CH:19]=[C:20]4[C:24](=[CH:25][CH:26]=3)[CH:23]([NH:27][C:28](=[O:31])[CH2:29][CH3:30])[CH2:22][CH2:21]4)[CH2:14]2)[CH:6]=[C:7]([C:9]([F:12])([F:11])[F:10])[CH:8]=1.C([O:40]C(=O)C)C.C(=O)([O-])O.[Na+]>O.C(#N)C.FC(F)(F)C(O)=O.N1C=CC=CC=1C([O-])=O.[Ag+2].N1C=CC=CC=1C([O-])=O>[F:37][C:2]([F:36])([F:1])[C:3]1[CH:4]=[C:5]([C:13]2([C:32]([F:35])([F:34])[F:33])[CH2:17][CH2:16][N:15]([C:18]3[CH:19]=[C:20]4[C:24](=[CH:25][CH:26]=3)[CH:23]([NH:27][C:28](=[O:31])[CH2:29][CH3:30])[CH2:22][CH2:21]4)[CH:14]2[OH:40])[CH:6]=[C:7]([C:9]([F:10])([F:12])[F:11])[CH:8]=1참가 물질
반응물 3
생성물 1
시약·촉매·용매 4
실험 절차
131 mg (0.243 mmole) N-(5-{3-[3,5-bis(trifluoromethyl)phenyl]-3-(trifluoromethyl)pyrrolidin-1-yl}-2,3-dihydro-1H-inden-1-yl)propanamide (Ex. No. (II-a-963), known from WO 2010/043315, Table 6, Ex. No. 273) was dissolved in a solution of 0.6 ml water, 6 ml acetonitrile and 1.2 ml trifluoroacetic acid. At 0° C. 86 mg (0.243 mmole) silver-(II)2-pyridinecarboxylate were added in small portions until the solution has been discoloured. Immediately after decolourization ethylacetate and sodium hydrogencarbonate solution were added. The aqueous solution was extracted additionally two times with ethylacetate. The combined extracts were dried and evaporated under reduced pressure. The residue was purified by a reversed phase chromatography with a gradient acetonitrile/water to obtain 9 mg (5.8%) of the title compound as a mixture of isomers. NMR data are given for the main isomer.
후처리
- customAt 0° C
- extractionThe aqueous solution was extracted additionally two times with ethylacetate
- customThe combined extracts were dried
- customevaporated under reduced pressure
- customThe residue was purified by a reversed phase chromatography with a gradient acetonitrile/water
출처 및 근거
- ORD 기록
- ord-aff3313145be4865a6dddce188cf5f4a
- 출처 데이터셋
- uspto-grants-2015_12
- 특허 번호
- US09206122B2
반응 노트
불러오는 중…